Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
1 other identifier
observational
60
1 country
1
Brief Summary
It is aimed to compare the ocular findings in patients with natural and surgical menopause.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2022
CompletedApril 18, 2022
April 1, 2022
1.6 years
January 1, 2021
April 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Macular thickness measurement
Macular thickness(micron) in both eyes will be measured by optical coherence tomography,
3 months after menopause
Detecting lens opacities
Lens opacities (Grade 1,2,3,4) will be measured by indirect biomicroscopy,
3 months after menopause
Intraocular pressure measurement
Intraocular pressures( mm Hg) will be measured and recorded with the applanation tonometry device.
3 months after menopause
Comparison of all detected data
All numerical data will be analyzed and compared with relevant statistical tests and the p value will be accepted as less than 0.05 to be considered a statistically significant difference.
3 months after menopause
Study Arms (2)
Natural menopause(Control group)
Female patients between 45-60 years of age diagnosed with menopause without any intervention
Surgical Menopause (Case group)
Female patients aged 45-60 years included in the study 3 months after bilateral oophorectomy and hysterectomy
Interventions
The incidence of macular thickness, Corneal thickness, intraocular pressure and lens opacities will be investigated by an ophthalmologist.
Eligibility Criteria
Will be studied in a patient population with low sociocultural level.
You may qualify if:
- Newly diagnosed menopause (Natural or Surgical Menopause( At least 3 months after surgery),
- No history of illness(Diabetes,Heart disease,Kidney disease etc.)
- Not Smoking
- Did not use alcohol
- Have not use any medication
- Age between 45-65 years
- BMI between 20-25 kg/m
You may not qualify if:
- Smoking or Alchohol consumption
- Age before 45 and after 65 years
- Have chronic disease
- Using any medication
- Have not diagnosed Menopause
- BMI greater than 30 kg/m
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Batman Maternity and Child Health Hospital
Batman, 72000, Turkey (Türkiye)
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
January 1, 2021
First Posted
January 11, 2021
Study Start
September 1, 2020
Primary Completion
March 23, 2022
Study Completion
March 23, 2022
Last Updated
April 18, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share